Loading...
Loading...
Shares of Exelixis
EXEL are lower on the session by 4.10%, currently trading at $7.49. The stock has been moving largely higher over the past three weeks and is currently trading above the 50-day moving average.
Options traders are focusing on puts today. A short while ago the November 2011 $6.00 put traded 570 times on open interest of 2,829 contracts.
Put volume is outpacing call volume by 4.5 to 1.
Exelixis, Inc. is a biotechnology company committed to developing small molecule therapies for the treatment of cancer. The company is focusing its resources and development efforts on cabozantinib.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in